Biomarin Pharmaceutical Inc (BMRN)

Operating profit margin

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Operating income (ttm)	US$ in thousands	187,212	161,154	122,435	94,357	74,639	149,562	108,182	57,380	29,900	-82,341	-67,976	-70,698	-123,315	-43,440	-1,087	58,864	58,455	-100,457	-129,443	-149,194
Revenue (ttm)	US$ in thousands	2,443,023	2,373,030	2,261,604	2,184,719	2,123,138	2,059,481	1,999,471	1,903,678	1,871,615	1,827,451	1,829,463	1,891,778	1,815,339	1,822,817	1,822,364	1,813,337	1,772,797	1,694,305	1,597,556	1,518,971
Operating profit margin		7.66%	6.79%	5.41%	4.32%	3.52%	7.26%	5.41%	3.01%	1.60%	-4.51%	-3.72%	-3.74%	-6.79%	-2.38%	-0.06%	3.25%	3.30%	-5.93%	-8.10%	-9.82%

March 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $187,212K ÷ $2,443,023K
= 7.66%

The operating profit margin of Biomarin Pharmaceutical Inc has displayed fluctuations over the periods provided. The trend shows improvement from negative margins in late 2021 to positive margins in 2022 and 2023, with values ranging from 1.60% to 7.66%. However, there are periods of decline as well, notably a decrease from 7.26% in Dec 2022 to 3.52% in Mar 2023. The operating profit margin peaked at 7.66% in Mar 2024, indicating the company's ability to generate profits from its core operations. Overall, Biomarin Pharmaceutical Inc has shown variability in its operating profit margin, demonstrating the importance of monitoring and managing operational performance.